Literature DB >> 18305033

Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.

Andreas Wiedmer1, Pu Wang, Jing Zhou, Andrew J Rennekamp, Valeria Tiranti, Massimo Zeviani, Paul M Lieberman.   

Abstract

Disruption of cellular metabolic processes and usurpation of host proteins are hallmarks of herpesvirus lytic infection. Epstein-Barr virus (EBV) lytic replication is initiated by the immediate-early protein Zta. Zta is a multifunctional DNA binding protein that stimulates viral gene transcription, nucleates a replication complex at the viral origin of lytic replication, and inhibits cell cycle proliferation. To better understand these functions and identify cellular collaborators of Zta, we purified an epitope-tagged version of Zta in cells capable of supporting lytic replication. FLAG-tagged Zta was purified from a nuclear fraction using FLAG antibody immunopurification and peptide elution. Zta-associated proteins were isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by mass spectrometry. The Zta-associated proteins included members of the HSP70 family and various single-stranded DNA and RNA binding proteins. The nuclear replication protein A subunits (RPA70 and RPA32) and the human mitochondrial single-stranded DNA binding protein (mtSSB) were confirmed by Western blotting to be specifically enriched in the FLAG-Zta immunopurified complex. mtSSB coimmunoprecipitated with endogenous Zta during reactivation of EBV-positive Burkitt lymphoma and lymphoblastoid cell lines. Small interfering RNA depletion of mtSSB reduced Zta-induced lytic replication of EBV but had only a modest effect on transcription activation function. A point mutation in the Zta DNA binding domain (C189S), which is known to reduce lytic cycle replication, eliminated mtSSB association with Zta. The predominantly mitochondrial localization of mtSSB was shifted to partly nuclear localization in cells expressing Zta. Mitochondrial DNA synthesis and genome copy number were reduced by Zta-induced EBV lytic replication. We conclude that Zta interaction with mtSSB serves the dual function of facilitating viral and blocking mitochondrial DNA replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305033      PMCID: PMC2293061          DOI: 10.1128/JVI.02198-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt.

Authors:  M Baumann; R Feederle; E Kremmer; W Hammerschmidt
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

3.  R-Loop in the replication origin of human mitochondrial DNA is resolved by RecG, a Holliday junction-specific helicase.

Authors:  T Ohsato; T Muta; A Fukuoh; H Shinagawa; N Hamasaki; D Kang
Journal:  Biochem Biophys Res Commun       Date:  1999-02-05       Impact factor: 3.575

4.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Herpes simplex virus eliminates host mitochondrial DNA.

Authors:  Holly A Saffran; Justin M Pare; Jennifer A Corcoran; Sandra K Weller; James R Smiley
Journal:  EMBO Rep       Date:  2006-12-22       Impact factor: 8.807

6.  Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.

Authors:  R Dardari; M Khyatti; A Benider; H Jouhadi; A Kahlain; C Cochet; A Mansouri; B El Gueddari; A Benslimane; I Joab
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

7.  Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus.

Authors:  M N Prichard; S Jairath; M E Penfold; S St Jeor; M C Bohlman; G S Pari
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.

Authors:  Martin Rowe; Britt Glaunsinger; Daphne van Leeuwen; Jianmin Zuo; David Sweetman; Don Ganem; Jaap Middeldorp; Emmanuel J H J Wiertz; Maaike E Ressing
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  Caenorhabditis elegans par2.1/mtssb-1 is essential for mitochondrial DNA replication and its defect causes comprehensive transcriptional alterations including a hypoxia response.

Authors:  Tomoko Sugimoto; Chihiro Mori; Takako Takanami; Yohei Sasagawa; Rumiko Saito; Eiichiro Ichiishi; Atsushi Higashitani
Journal:  Exp Cell Res       Date:  2007-08-25       Impact factor: 3.905

10.  Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication.

Authors:  Shao-An Xue; Beverly E Griffin
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more
  34 in total

1.  Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.

Authors:  Andrew J Rennekamp; Pu Wang; Paul M Lieberman
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.

Authors:  Pu Wang; Andrew J Rennekamp; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.

Authors:  Dinesh Verma; Chen Ling; Eric Johannsen; Tirumuru Nagaraja; Sankar Swaminathan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

6.  Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus.

Authors:  Ya-Chun Yang; Yushi Yoshikai; Shih-Wei Hsu; Hisato Saitoh; Li-Kwan Chang
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

7.  Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.

Authors:  Yaqi Zhou; Kate Heesom; Kay Osborn; Rajaei AlMohammed; Steve M Sweet; Alison J Sinclair
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

8.  Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments.

Authors:  Armel Nicolas; Nathalie Alazard-Dany; Coline Biollay; Loredana Arata; Nelly Jolinon; Lauriane Kuhn; Myriam Ferro; Sandra K Weller; Alberto L Epstein; Anna Salvetti; Anna Greco
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

9.  EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.

Authors:  M S Gilardini Montani; R Santarelli; M Granato; R Gonnella; M R Torrisi; A Faggioni; M Cirone
Journal:  Autophagy       Date:  2018-10-23       Impact factor: 16.016

10.  Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.

Authors:  Sarah G Bailey; Elizabeth Verrall; Celine Schelcher; Alex Rhie; Aidan J Doherty; Alison J Sinclair
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.